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National trends in venous disease
Geoffrey D. Barnes, MD,a Sameer Gafoor, MD,b Thomas Wakefield, MD,c Gilbert R. Upchurch Jr, MD,c
Peter Henke, MD,c and James B. Froehlich, MD, MPH,d Ann Arbor, Mich; and Washington, DC
Background: The national burden of venous disease and use of ultrasound (US) in the outpatient and emergency
department (ED) settings has not been well described. The objective of this study is to describe venous disease in the
outpatient and ED settings nationally as well as to characterize the use of US for diagnosis of venous disease, including
phlebitis.
Methods: Data from the 1997 to 2006 National Ambulatory Medical Care Survey (NAMCS) and National Hospital
Ambulatory Medical Care Survey (NHAMCS) were compiled, and complex sampling methods were used to describe the
number of outpatient and ED visits for adults given a diagnosis of venous disease or phlebitis by ICD-9 coding. Logistic
regression analysis with calculated odds ratios are used to examined patient visit characteristics and use of US.
Results:During the 10 years studied, an office or ED visit for venous disease occurred over 46million times, for an average
of 4.6 million visits per year, with this rate increasing from 4.03 million to 5.71 million per year (odds ratio [OR] 1.01,
confidence interval [CI] 1.00-1.01). The majority of these patients were seen by specialists, such as surgeons or
cardiologists, but a significant number were also seen by primary care providers (PCP). There were 2 million office visits
(PCP and specialists) on average per year with no significant increase. There were approximately 236,000 ED visits for
deep vein thrombosis (DVT) on average per year, which showed a small increase (OR 1.01, CI 1.00-1.01). Visits for DVT
and phlebitis were as likely to be seen by PCPs as ED physicians. Non-DVT venous disease is much more likely to be seen
by a surgeon (OR 4.88, CI 3.53-6.74) than a PCP. DVT is much less likely to be diagnosed by a specialist (OR 0.27, CI
0.18-0.29) than a PCP. Insurance status and geographic region were not associated with DVT or non-DVT venous
disease diagnosis.
Conclusions:Nationally, a significant and growing number of patients with venous disease are being seen in the outpatient
setting by PCPs and specialists. A significant number of patients with DVT are being seen in the outpatient setting, but
without a trend away from care in the ED over the 10-year study period. Additionally, the majority of patients with DVT
diagnosis do not seem to be getting ultrasounds at the same visit. Many of these patients are being seen by PCPs who may
require additional training and infrastructure for appropriate patient care. ( J Vasc Surg 2010;51:1467-73.)Venous diseases encompass a wide range of disorders,
from cosmetic (varicosities) to potentially life threatening
(deep vein thrombosis and pulmonary embolism). Al-
though there has been significant discussion about preven-
tion and management of inpatient deep vein thrombosis
(DVT), there has not been a good description of the overall
volume of venous disease. Some of the limited American
population-based prospective data of venous disease prev-
alence in the adult population is from a 1973 study in
southeast Michigan, where an estimated 3% had venous
stasis changes, 0.2% had venous ulcers and varicose veins
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doi:10.1016/j.jvs.2009.12.070were present in 12.9% of men and 25.9% of women.1,2
Other studies, mostly outside the United States, have
found varicose veins to have a prevalence range of less than
1% to 73%, depending on the population examined.2,3
With regards to outpatient DVT prevalence, an esti-
mated 2.6% of nonsurgical patients admitted to a German
hospital’s department of internal medicine with acute ill-
ness had a diagnosis of DVT, presumably present prior to
admission.4 A Massachusetts based study of all patients
diagnosed with DVT in the hospital setting found that 74%
had presented to the emergency department (ED) with
these symptoms, suggesting the disease develops primarily
in the outpatient setting.5 The same group found a preva-
lence of 104 per 100,000 population for venous thrombo-
embolism and 92 per 100,000 population for DVT, inde-
pendent of where they were diagnosed.6
To the best of our knowledge, no study has looked at
the outpatient office and ED burden, nationally, of both
DVT and non-DVT venous disease. This study analyzes
national provider survey data in an attempt to describe the
overall clinical burden of venous disease in the outpatient
setting and to describe patient characteristics, provider
characteristics, and provider approaches to diagnosis with
an emphasis on ultrasound use.
METHODS
Data source. Data from 1997 to 2006 of the National
Ambulatory Medical Care Survey (NAMCS) and National
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were combined to generate a comprehensive, national es-
timate of patient visit characteristics in the outpatient and
emergency department (ED) setting. Complete descrip-
tion and survey data is available at http://www.cdc.gov/
nchs/about/major/ahcd/ahcd1.htm. NAMCS surveys
office-based (non-hospital) physician visits, while NHAMCS
surveys hospital-based outpatient and emergency depart-
ment visits. For these surveys, standard encounter forms
were completed for a random selection of patients, among
a nationally representative sample of providers. Encounter
forms vary slightly from year to year, with updates every 2
years. Data used for this analysis was common to both
surveys, including patient demographics, visit characteris-
tics, physician diagnosis, and diagnostic tools. For hospital
admission rates, data used from the NHAMCS ED survey
includes visit disposition.
Study sample. Men and women ages 18 years and
greater were included with any diagnosis encompassing
venous disease. Specific diagnoses were identified using
the International Classification of Disease Ninth Revision
(ICD-9) coding. The population of all venous disease was
further divided into DVT (including phlebitis) and non-
DVT venous disease. Specific ICD-9 codes can be found in
the Appendix. Ultrasound use was compiled from a specific
entry on the encounter form when available (1997-2002,
2005-2006) and using the ICD-9 code 887.7 for diagnos-
tic procedures. Other diseases that may also necessitate
ultrasound use include: renal disease, liver disease, gallblad-
der disease, gastrourinary disease, and breast disease. These
were identified using appropriate ICD-9 codes and were
excluded or controlled for in analysis on ultrasound (US)
use (Appendix).
Patient visit characteristics. Demographic patient visit
characteristics evaluated include patient age, gender, race/
ethnicity, medical insurance, ultrasound census region,
metropolitan area status, physician specialty, and practice
setting. Medical insurance was classified as private/
commercial insurance, Medicare, Medicaid, and other in-
surance (eg, worker’s compensation and self-pay). Physi-
cian specialty was categorized as primary care (PCP; family
medicine and general internal medicine), emergency med-
icine, cardiology, surgery, and other.
Outcome measures. The burden of venous disease
was described in both the outpatient office setting and the
ED. Specific descriptors include estimating the total num-
ber of office/ED visits, gender, age, race, specialty of
physician visited, geographic region, insurance coverage,
and rate of hospital admission from the ED for the diag-
noses of all venous disease, DVT only and non-DVT ve-
nous disease. We also examined the use of ultrasound in
making a diagnosis of venous disease diagnosis and its
change over the 10-year study period.
Statistical analysis. Statistical analysis was performed
using SPSS Version 16 with Complex Samples module
(Chicago, Ill). The unit of analysis was the patient visit.
Data from the two surveys (NAMCS and NHAMCS) werecombined to obtain a wider range of outpatient settings
and to make comparisons between ED and outpatient
visits. Masked design variables were created based on in-
structions provided by the National Center for Health
Statistics to account for the multistage design (http://
www.cdc.gov/nchs/data/ahcd/ultimatecluster.pdf). Be-
cause of the multistage complex sample design, appropriate
weighting was incorporated for national visit estimates.
To generate visit descriptors, three logistic regression
analyses were performed on the entire data set with all
venous disease, DVT/phlebitis or non-DVT venous dis-
ease vs other diagnoses as the dependent variables and
using the same set of predictors (Table). Odds ratios (OR)
with 95% confidence intervals (CI) were estimated for
various visit descriptors. To analyze trend in ultrasound use
for diagnosis of DVT, logistic regression analysis was per-
formed with the subpopulation of DVT diagnosis and
dependent variable of ultrasound use considering year as a
continuous variable with a one year step. Odds ratio for a
one year step was calculated including and excluding 2006
(considered a possible outlier). To analyze trends in total
venous disease and non-DVT venous disease, a logistic
regression analysis was performed on all visits with either
total venous disease or non-DVT venous disease diagnosis
as the dependent variable and year as a continuous variable
with a one year step. To analyze trends in DVT diagnosis in
the ED, a logistic regression analysis was performed on the
subpopulation of all ED visits with DVT diagnosis as the
dependent variable and year as a continuous variable with a
one year step. To analyze ultrasound use between ED and
outpatient settings, a logistic regression analysis was per-
formed with the subpopulation of DVT diagnosis and use
of ultrasound as the dependent variable with an OR and
95% interval calculated. To compare ultrasound use be-
tween the diagnosis of DVT and non-DVT venous disease,
a logistic regression analysis was performed with the sub-
population of all venous diagnosis and dependent variable
of ultrasound use with an OR and 95% CI being calculated
for DVT vs non-DVT venous diagnosis. To compare ultra-
sound use for DVT diagnosis by age, a logistic regression
analysis was performed with the subpopulation of DVT
diagnosis and dependent variable of ultrasound use andOR
with 95% CIs calculated comparing each age group (18-24,
25-44, 45-64, 65-74 years) against age 75. To compare
rates of admission from the ED, a logistic regression anal-
ysis was performed on the subset of ED visits with a
dependent variable of hospital admission and OR with 95%
CI calculated for DVT vs non-DVT venous diagnosis. To
compare trend in admission over time, a logistic regression
analysis was performed on all DVT and non-DVT venous
disease diagnosis, respectively, with a dependent variable of
hospital admission and year as a continuous variable with a
one year step. All analyses were performed in a multivar-
iate fashion and, when appropriate, controlled for age,
gender, race, physician specialty, and visit locations (out-
patient vs ED).
dels.
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Patient characteristics. As seen in the Table, over the
10-year study period, there were approximately 46 million
ED and office visits where the reason for visit or diagnosis
given was venous disease. Approximately 20 million visits
were for DVT or phlebitis. In the ED, slightly more than 4
million were for all venous diseases and 2.4million for DVT
or phlebitis. In the general outpatient setting, visits for total
venous disease were 24% (CI 12%-35%) less likely to be
women than men. Non-DVT venous disease was 32% (CI
19%-43%) less likely to be women than men. DVT/phle-
bitis visits showed no gender preference. Non-DVT venous
disease was more likely to be seen in a surgeon’s office than
a primary care office (OR 4.88, CI 3.53-6.74). DVT diag-
nosis was less likely to be made by a cardiologist than by a
PCP (OR 0.36, CI 0.21-0.61) and by other physicians than
a PCP (OR 0.27, CI 0.18-0.39). DVT diagnosis was
equally as likely at a surgeon’s office and the ED compared
with a PCP’s office. There was no association with geo-
graphic location for any form of venous disease.
There was no strong prevalence for private, Medicaid,
or Medicare insurance, compared with no insurance for all
forms of venous disease. Non-DVT venous disease was
more likely to present in older adults age 75 years old
than those 64 years old and younger. DVT venous disease
Table. Predictors of venous disease diagnosis at office and
Characteristic All venous
Total visits (10 y, in millions) 46.41 (39.41-53.
Total ED visits (10 y, in millions) 4.15 (3.68-4.62
Gender (female vs male) 0.76 (0.65-0.88)
Specialty
Surgeon vs PCP 2.54 (1.91-3.36)
ED vs PCP 0.93 (0.81-1.07
Card vs PCP 0.47 (0.31-0.7)
Other vs PCP 0.53 (0.33-0.83)
Geographic
NE vs W 0.74 (0.49-1.12
MW vs W 0.75 (0.5-1.13)
S vs W 0.7 (0.47-1.04
Private ins
Private vs none 1.17 (0.8-1.72)
Medicaid
vs none 1.38 (0.94-2.0)
Medicare
vs none 1.19 (0.82-1.72
Other ins
vs none 1.49 (0.94-2.34
Age (y)
18-24 vs 75 0.05 (0.03-0.09)
25-44 vs 75 0.45 (0.33-0.61)
45-64 vs 75 0.74 (0.57-0.97)
65-75 vs 75 0.89 (0.73-1.09
Race
Black vs White 0.9 (0.74-1.09
Other vs White 0.51 (0.31-0.85)
DVT,Deep venous thrombosis; ED, emergency department; PCP, primary c
All above elements were included in the multivariate logistic regression mo
ORs in bold/italics are statistically significant. Odds ratios are provided witwas more likely to present in older adults greater than 75years old than those 44 years old and younger. Both DVT
and non-DVT venous disease were equally prevalent in
white and black adults, but DVT was less likely in other
racial minorities compared with whites.
Presentation rates with venous disease. Over the
years 1997 to 2006, total visits for venous disease increased
from 4,034,000 in 1997 to 5,708,000 in 2006 with a peak
of 7,376,000 in 2004, suggesting an increasing trend (OR
1.005, CI 1.002-1.008). Non-DVT venous disease also
experienced an increase from 2,159,000 in 1997 to
3,711,000 in 2006 with a peak of 4,884,000 in 2004 with
logistic regression analysis showing a slight positive trend
(OR 1.006, CI 1.002-1.011). Total visits for DVT stayed
relatively stable from 1,874,000 in 1997 to 1,998,000 in
2006 with a peak of 2,492,000 in 2004 (Fig 1) with the
majority of visits in the office setting (Fig 2). Logistic
regression analysis for the years ranging 1997 to 2006 does
not show any significant change in frequency of ED diag-
nosis of DVT (OR 1.001, CI 0.998-1.004).
Ultrasound use in venous disease diagnosis. Ultra-
sound use for all venous disease ranged from 7% in 2001 to
22% in 2006. Ultrasound use for DVT diagnosis declined
from 25% in 1998 to 8% in 2005, then jumped to 25% in
2006. Logistic regression modeling for ultrasound use in
DVT diagnosis for the year range 1997 to 2006 did not
visits
DVT/phlebitis Venous not DVT
20.01 (17-23.02) 26.4 (20.76-32.04)
2.36 (2.04-2.67) 1.72 (1.53-2.06)
0.87 (0.71-1.06) 0.68 (0.57-0.81)
0.82 (0.52-1.31) 4.88 (3.53-6.74)
0.97 (0.8-1.17) 0.93 (0.74-1.17)
0.36 (0.21-0.61) 0.62 (0.35-1.08)
0.27 (0.18-0.39) 0.9 (0.48-1.69)
0.92 (0.65-1.32) 0.65 (0.36-1.17)
0.99 (0.68-1.43) 0.63 (0.35-1.17)
1.0 (0.75-1.34) 0.55 (0.3-1.0)
1.24 (0.74-2.05) 1.12 (0.68-1.87)
1.21 (0.75-2.05) 1.49 (0.92-2.41)
1.23 (0.75-2.0) 1.13 (0.69-1.83)
0.99 (0.56-1.75) 1.81 (1.04-3.15)
0.06 (0.02-0.14) 0.05 (0.03-0.08)
0.34 (0.23-0.5) 0.55 (0.36-0.82)
0.62 (0.43-0.89) 0.86 (0.61-1.21)
0.89 (0.65-1.23) 0.89 (0.68-1.16)
0.82 (0.6-1.13) 0.96 (0.72-1.29)
0.42 (0.19-0.93) 0.59 (0.32-1.08)
ysician;Card, cardiologist;NE, northeast;W,west;MW,midwest; S, south.
confidence intervals in parentheses.ED
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)
)
)
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are phshow a trend of use (OR 1.0, CI 0.99-1.01). When exclud-
isits f
or de
JOURNAL OF VASCULAR SURGERY
June 20101470 Barnes et aling 2006 as an outlier and repeating the model for 1997 to
2005, ultrasound use in DVT diagnosis does show a slight
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venography, were not able to be measured.
Logistic regression modeling shows that patients with
DVT diagnosis are 1.97 times (CI 1.32-2.91) more likely
to receive ultrasound for diagnosis in the ED compared
with outpatient offices, when controlling for race, age, sex,
and other disease. Logistic regression modeling shows that
DVT diagnoses are more likely to be made with ultrasound
testing than non-DVT diagnosis, when controlled for race,
age, physician specialty, year, sex, and other disease (OR
2.05, CI 1.25-3.37). Logistic regression analysis shows that
ultrasound use for diagnosing DVT is not influenced by
patient age when controlled for race, physician specialty,
sex, and other diseases. The OR for various ages ranged
from 0.48-1.75 with CIs that are all nonsignificant.
Trends in hospital admission from the ED. Of pa-
tients presenting to the ED, logistic regression analysis
shows that non-DVT venous disease is less likely (OR
0.097, CI 0.059-0.157) than DVT diagnosis to be admit-
ted to the hospital, when controlling for race, age, year, sex,
and other diseases. Rates of hospital admission from the ED
for DVT diagnosis ranged from 28.4% (CI 19%-40%) in
2004 to 50.8% (CI 35.9%-65.5%) in 2003. Over the study
period, there was no trend in frequency of DVT admissions
(OR 1.002, CI 0.996-1.009) or non-DVT venous disease
admissions (OR 0.987, CI 0.974-1.001).
DISCUSSION
Describing the national burden of venous disease.
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Fig 3. Deep venous thrombosis ultrasoundThe national burden of venous disease as a whole is large,with over 4.6million office and ED visits per year, and likely
growing (for comparison, there were approximately 9.4
million office visits for nasal congestion in 2006).7 Second,
as may be predicted, non-DVT venous disease is seen far
more often by surgeons than other practitioners. Third,
office and ED visits for non-DVT venous disease are grow-
ing, and outnumber DVT visits. Fourth, DVT diagnoses
tend to be made equally by PCPs, surgeons, and ED
physicians without any trend over the 10-year study period.
Although much attention is given to the prevention of
DVT in the inpatient setting, our study suggests that DVT
in the outpatient setting is also a significant national health
issue. Perhaps most strikingly, the burden of care for DVT
has not shifted away from the ED setting, based on the
logistic regression model. This begs the question of appro-
priate use of ED resources, especially if patients do not have
symptoms suggesting possible pulmonary involvement.
Compared with DVT diagnosis, non-DVT venous dis-
ease represents an equally large national burden for outpa-
tient and ED physicians. While rates of DVT visits to the
office or ED have stayed stable over the 10-year period,
there has been an increase in visits for non-DVT venous
disease in that same time period. We must ask if primary
care physicians are adequately trained and equipped to treat
this growing disease population.
The majority of the DVT literature focuses on ED
diagnosis and inpatient treatment of DVTs. However, this
study suggests that PCPs are also seeing a significant portion
of the population given a DVT diagnosis and may benefit
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patient management of DVT is usually recommended, our
data suggests that many DVT diagnoses are made in the ED,
with no change over the 10 years studied. Resources and
infrastructure are needed for the PCP to effectively diagnose
and treat DVT in the outpatient setting without reliance on
the ED. The availability of these resources is not clear.
As expected, both DVT and non-DVT venous diseases
are chronic illnesses that preferentially affect the elderly.
Although there does not seem to be a racial difference in
any form of venous disease comparing whites and blacks,
other ethnic minorities do tend to have lower rates of DVT
diagnosis in the office or ED.
Trend in ultrasound use for diagnosis of venous
disease. Ultrasound is commonly used as a noninvasive
means to assess for DVT and other forms of venous disease.
Interestingly, we found a trend towards decreasing rate of
ultrasound use in DVT patients. In fact, if 2006 data is
excluded as an outlier, there is a small but statistically
significant decline in yearly reported use of ultrasound for
DVT patients in the ambulatory care setting found in the
stepwise logistic regression model. Unfortunately, 2007
data was not available to support the argument that 2006
ultrasound use in DVT patients is truly an outlier. Part of
this trend is possibly attributed to increasing use of com-
puted tomography scanning (CT) to evaluate for pulmo-
nary embolism (PE) and its concurrent evaluation of prox-
imal lower extremity veins for venous clot.8 As such, when
a CT scan is ordered in the ED setting to evaluate for PE,
thrombus seen in the lower extremities is diagnostic of
DVT without the use of ultrasound. Our data specifically
do not include PE in the DVT/phlebitis diagnosis group.
We were not able to evaluate rates of CT use in DVT
diagnosis over our entire data set, but further investigation
is warranted. Although it may seem logical that all patients
with venous disease undergo some form of ultrasound, this
was not observed in this study and therefore further inves-
tigation into reasoning is warranted. It is possible that some
patients get an ultrasound in the ED because none is
available in the PCP’s office, but only their PCP visit is
captured in this study. Likewise, some patients presenting
to the ED may have already undergone ultrasound by their
outpatient physician, but only the ED visit was captured by
this study. Lastly, because we chose to exclude patients with
other potential reasons for ultrasound use, we likely were
unable to capture the entirety of ultrasound use for the
purpose of venous disease diagnosis. Availability of ultra-
sound in the outpatient setting is certainly a limiting factor
for PCPs and other outpatient physicians to make appro-
priate DVT diagnosis.
As could be predicted, logistic regression analysis sug-
gests that ultrasound is used nearly twice as often to diag-
nose DVT in the ED than in the outpatient setting. This
may be attributed to initial diagnoses being made with
ultrasound in the ED and follow-up visits with the same
diagnosis occurring in the clinic setting. This could also
occur if PCPs send suspected, but not definitively diag-
nosed, patients with DVT to the ED. Lastly, this may beinfluenced by availability of ultrasound in the ED compared
with the office setting. When comparing DVT with non-
DVT diagnosis, DVT diagnosis is more than three times as
likely to be associated with the use of ultrasound. However,
when DVT was diagnosed, the patient’s age does not
influence the use of ultrasound.
Trend in hospital admission from the ED. As ex-
pected, when a diagnosis of DVT is made in the ED, it is
about 10 times as likely to result in admission compared
with non-DVT venous disease. Current standard of care is
to hospitalize most, if not all, newly diagnosed cases of
pulmonary embolism. It is possible that these patients are
given the dual diagnosis of PE and DVT in this study,
therefore confounding our data (which only observedDVT
diagnosis) and as such, makes it difficult to comment on the
appropriateness of admission. Additionally, despite studies
showing that outpatient management of DVT with low
molecular weight heparin and warfarin has been shown to be
appropriate, this study showed no evidence of decreasing
admission rates for patients with DVT diagnosis in the ED.9
CONCLUSIONS
Overall, venous disease is a significant public health
concern in the United States that is increasing in frequency.
For patients with DVT, there has not been a trend away
from ED diagnosis. Rather, the number of visits for DVT
has stayed relatively constant in both the ED and PCP office
setting. This finding questions if additional training and
infrastructure are needed to assist PCPs in appropriate care
for patient with DVT. There has been an increase in the
number of office visits for non-DVT venous disease over
the same time period, seen predominantly by surgeons.
Lastly, there has been a suggestion of decreasing ultra-
sound use in DVT patients. Appropriateness of outpatient
diagnostic ultrasound, especially as a noninvasive and non-
radiating test, certainly warrants further evaluation.
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diagnoses:
● DVT/phlebitis defined as ICD 9 codes 451, 453.1,
453.4, 453.8, 453.9
● Non-DVT/phlebitis venous disease defined as ICD 9
codes 454, 459.1, 415.1, 415.11, 459.2, 671.2,
671.3, 671.4, 707.13, 729.81, 997.2, 999.2
● All venous disease is a combination of the two above
ICD 9 code sets
● Renal disease was defined by ICD 9 codes 580-
593
● Liver disease was defined by ICD 9 codes 570-
573
● Gallbladder disease was defined by ICD 9 codes 574-
576
● Gastrourinary and breast disease was defined by
ICD 9 codes 594-599, 603, 608.1-608.4, 610,
614-629
